Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, PR China.
Drug Dev Ind Pharm. 2010 Dec;36(12):1469-76. doi: 10.3109/03639045.2010.488645. Epub 2010 Jun 6.
Triamcinolone acetonide palmitate (TAP) is a lipophilic prodrug of triamcinolone acetonide (TAA) to improve the insoluble TAA physicochemical properties for the preparation of emulsions.
This investigation has focused on the preformulation study of TAP, including its physicochemical properties and hydrolysis kinetics in vitro.
The solubility of TAP in medium-chain triglyceride is about twice greater than that in soybean oil (long-chain triglyceride) (19.17 versus 9.55 mg/g) at 25°C, and in all investigated cases, lecithin (80, 160, and 240 mg/g) as solubilizer provided increased solubility of drugs in medium-chain triglyceride and long-chain triglyceride, whereas the maximum water solubility of TAP was 0.10 μg/mL. The partition coefficient (log P) of TAP was 5.79 irrespective of the pH conditions. The hydrolysis of TAP followed pseudo-first-order kinetics in aqueous solutions, and the stable pH range was from pH 5.0 to 9.0. The in vitro enzymolysis kinetics of TAP in rat plasma and liver homogenate was evaluated by measuring the decrease of TAP as well as the increase of TAA at 37°C for 96 hours. The results demonstrated that the TAP may be hydrolyzed mainly by rat plasma esterase and, to a minor extent, by liver esterase, and the hydrolysis half-life of TAP in 100% rat plasma was 17.53 ± 6.85 hours at pH 7.4.
All these results indicated that TAP had successfully obtained higher lipid-soluble property for the preparation of intravenous emulsion and may be an effective prodrug for sustained release of TAA in vivo.
曲安奈德棕榈酸酯(TAP)是曲安奈德(TAA)的亲脂性前药,可改善难溶性 TAA 的理化性质,用于制备乳剂。
本研究重点对 TAP 的预配方进行研究,包括其理化性质和体外水解动力学。
在 25°C 下,TAP 在中链甘油三酯中的溶解度约为大豆油(长链甘油三酯)中的两倍(19.17 与 9.55mg/g),而在所有研究情况下,作为增溶剂的卵磷脂(80、160 和 240mg/g)可增加药物在中链甘油三酯和长链甘油三酯中的溶解度,而 TAP 的最大水溶解度为 0.10μg/mL。TAP 的分配系数(log P)无论 pH 条件如何均为 5.79。TAP 在水溶液中的水解遵循拟一级动力学,稳定的 pH 范围为 5.0 至 9.0。通过测量 TAP 的减少以及 TAA 在 37°C 下 96 小时的增加,评估 TAP 在大鼠血浆和肝匀浆中的体外酶解动力学。结果表明,TAP 可能主要通过大鼠血浆酯酶水解,其次是肝酯酶,在 pH 7.4 下,TAP 在 100%大鼠血浆中的水解半衰期为 17.53±6.85 小时。
所有这些结果表明,TAP 已成功获得更高的脂溶性,可用于制备静脉乳剂,并且可能是 TAA 体内持续释放的有效前药。